Intuitive Surgical Stock Rises After Cramer Endorsement

Robotics company's shares up 23% since Cramer's June 2025 comments

Mar. 28, 2026 at 1:49pm by Ben Kaplan

Got story updates? Submit your updates here. ›

Intuitive Surgical, Inc. (NASDAQ:ISRG), a leading medical robotics company, saw its stock price rise 23% since Jim Cramer discussed the company favorably on CNBC in June 2025. The stock surged 27% in October 2025 after the company reported strong Q3 earnings, but has since declined slightly on concerns about funding cuts and competition.

Why it matters

Intuitive Surgical is a pioneer in the growing field of robotic surgical systems, which have become increasingly important in modern healthcare. Cramer's endorsement of the stock highlights the company's prominence and the potential upside for investors, though concerns remain about the competitive landscape and regulatory environment.

The details

Intuitive Surgical's shares are down 7.8% over the past year, but have risen 23% since Cramer discussed the company on CNBC's 'Squawk on the Street' in June 2025. The stock surged 27% in the middle of October 2025 after the company reported Q3 earnings that beat analyst estimates. However, the stock closed 2.7% lower on January 14, 2026 after the company released preliminary Q4 earnings and commented that funding cuts and rival products could slow growth of its robotic surgical system.

  • On June 6th, 2025, Cramer discussed Intuitive Surgical on CNBC.
  • In October 2025, Intuitive Surgical's stock price surged 27% after the company reported strong Q3 earnings.
  • On January 14, 2026, Intuitive Surgical's stock closed 2.7% lower after the company released preliminary Q4 earnings.

The players

Intuitive Surgical, Inc.

A leading medical robotics company that develops and manufactures the da Vinci Surgical System, a robotic surgical platform used in minimally invasive procedures.

Jim Cramer

A financial commentator and host of CNBC's 'Mad Money' program, who discussed Intuitive Surgical favorably in June 2025.

Got photos? Submit your photos here. ›

What they’re saying

“I want to just mention that you're getting an opportunity here to buy Intuitive Surgical. It pre-announced last week at San Francisco. I thought, uh don't, I wanted to add it to the club, to the charitable trust. And then it just took off. It was a star, of, of San Francisco, star of the conference. And then they announced the regular quarter today and people suddenly don't like it. Give me a break. Just go buy ISRG. It's fantastic.”

— Jim Cramer, Financial Commentator

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

Intuitive Surgical's stock performance highlights the potential upside for investors in leading medical robotics companies, though concerns remain about competition and regulatory headwinds. Cramer's endorsement underscores the company's prominence, but investors should also consider other AI-driven healthcare stocks that may offer greater long-term potential.